Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-08-25 Verratti Mark President, Myriad Neuroscience Shares withheld for taxes −1,082 $34.81 $38K 156,048
2021-08-25 LANCHBURY JERRY S Chief Scientific Officer Shares withheld for taxes −2,233 $34.81 $78K 230,317
2021-08-24 LANCHBURY JERRY S Chief Scientific Officer Exercise or conversion +30,000 $27.07 $812K 262,550
2021-08-24 LANCHBURY JERRY S Chief Scientific Officer Sale −30,000 $35.57 $1.1M 232,550
2021-08-24 LANCHBURY JERRY S Chief Scientific Officer Exercise or conversion · Non-Qualified Stock Option (right to buy) −30,000 0
2021-08-23 LANCHBURY JERRY S Chief Scientific Officer Exercise or conversion +10,000 $27.07 $271K 242,550
2021-08-23 LANCHBURY JERRY S Chief Scientific Officer Sale −10,000 $35.57 $356K 232,550
2021-08-23 LANCHBURY JERRY S Chief Scientific Officer Exercise or conversion +40,000 $27.07 $1.1M 272,550
2021-08-23 LANCHBURY JERRY S Chief Scientific Officer Sale −40,000 $35.07 $1.4M 232,550
2021-08-23 LANCHBURY JERRY S Chief Scientific Officer Exercise or conversion · Non-Qualified Stock Option (right to buy) −10,000 70,000
2021-08-23 LANCHBURY JERRY S Chief Scientific Officer Exercise or conversion · Non-Qualified Stock Option (right to buy) −40,000 30,000
2021-08-13 DIAZ PAUL J President and CEO Shares withheld for taxes −58,820 $32.79 $1.9M 400,049
2021-08-10 Riggsbee Richard Bryan Chief Financial Officer Gift −3,250 321,692
2021-08-05 Phanstiel S. Louise Director Exercise or conversion +30,000 $25.39 $762K 109,527
2021-08-05 Phanstiel S. Louise Director Sale −47,881 $35.04 $1.7M 61,646
2021-08-05 Phanstiel S. Louise Director Exercise or conversion +30,000 $21.29 $639K 91,646
2021-08-05 Phanstiel S. Louise Director Exercise or conversion · Non-Qualified Stock Option (right to buy) −30,000 0
2021-08-05 Phanstiel S. Louise Director Exercise or conversion · Non-Qualified Stock Option (right to buy) −30,000 0
2021-08-05 LANCHBURY JERRY S Chief Scientific Officer Exercise or conversion +28,225 $27.07 $764K 260,775
2021-08-05 LANCHBURY JERRY S Chief Scientific Officer Sale −28,225 $35.57 $1.0M 232,550

Page 23 of 35 · 689 trades